Stayble Therapeutics AB (publ) (STABL.ST)
SEK 0.39
(1.56%)
SEK 0.39
(1.56%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.92 SEK | 45.88% |
| 2022 | -1.70 SEK | -100.0% |
| 2021 | -0.85 SEK | 52.78% |
| 2020 | -1.80 SEK | -185.71% |
| 2019 | -0.63 SEK | 8.7% |
| 2018 | -0.69 SEK | -115.62% |
| 2017 | -0.32 SEK | -128.57% |
| 2016 | -0.14 SEK | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.11 SEK | 45.0% |
| 2024 Q2 | -0.11 SEK | 0.0% |
| 2023 FY | - SEK | 55.88% |
| 2023 Q3 | -0.22 SEK | 15.38% |
| 2023 Q1 | -0.27 SEK | 20.59% |
| 2023 Q2 | -0.26 SEK | 3.7% |
| 2023 Q4 | -0.20 SEK | 9.09% |
| 2022 FY | - SEK | -100.0% |
| 2022 Q3 | -0.40 SEK | 11.11% |
| 2022 Q2 | -0.45 SEK | 16.67% |
| 2022 Q1 | -0.54 SEK | -68.75% |
| 2022 Q4 | -0.34 SEK | 15.0% |
| 2021 Q1 | -0.15 SEK | -25.0% |
| 2021 FY | - SEK | 52.78% |
| 2021 Q3 | -0.21 SEK | -16.67% |
| 2021 Q2 | -0.18 SEK | -20.0% |
| 2021 Q4 | -0.32 SEK | -52.38% |
| 2020 Q1 | -0.76 SEK | -5.56% |
| 2020 Q2 | -0.90 SEK | -18.42% |
| 2020 Q4 | -0.12 SEK | 58.62% |
| 2020 FY | - SEK | -185.71% |
| 2020 Q3 | -0.29 SEK | 67.78% |
| 2019 Q2 | -0.24 SEK | 31.43% |
| 2019 Q1 | -0.35 SEK | -84.21% |
| 2019 Q4 | -0.72 SEK | -380.0% |
| 2019 FY | - SEK | 8.7% |
| 2019 Q3 | -0.15 SEK | 37.5% |
| 2018 Q4 | -0.19 SEK | 0.0% |
| 2018 FY | - SEK | -115.62% |
| 2017 FY | - SEK | -128.57% |
| 2016 FY | - SEK | 0.0% |